An integrated analysis of 23,634 individuals identified 235 circulating metabolites associated with future risk of type 2 diabetes and revealed their potential genetic and environmental determinants.

Vicarious Surgical (NYSE: RBOT) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the successful completion of an ...

Endocrine reproductive disorders are disorders that affect the reproductive endocrine system and often result in fertility problems. Examples include ovarian insufficiency and polycystic ovary ...

NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables ...

The Association of Medical Laboratory Scientists of Nigeria (AMLSN) has warned that the growing trend of pharmacies conducting medical tests across the country is illegal and poses a serious public ...

Microplastics have shifted from an abstract pollution problem in distant oceans to a concrete health issue inside our own ...

Astrologer and writer Meghan Rose used manifestation to help clear her own skin (along with getting her dream job and meeting ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Scientists have taken a major step toward improving how wastewater treatment systems deal with emerging contaminants such as ...

Rule protects cashiers, shoppers, families from hormone-disrupting chemicals; New data show many major retailers have already restricted bisphenols nationwide By banning all bisphenols in receipts, ...

The BioXplorer 5000 is a lab-scale bioreactor platform available in sizes ranging from 1-5L and in high- and low-pressure variants. It can be utilized for a huge variety of applications, ranging from ...

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and technologies that improve patient outcomes. Editor’s Note: This is part three ...